OpenBind

About OpenBind

OpenBind is a collaborative initiative centered on building the world’s largest open-access dataset of drug–protein interactions to accelerate drug discovery. By combining advanced chemistry, high-throughput X-ray crystallography, and AI-powered analysis, it aims to enable structure-based drug design tools that are freely available to researchers worldwide. The project is led by Diamond Light Source and involves major academic and research partners in the UK and internationally, with a focus on expanding public data and accelerating discovery. Located in the UK, OpenBind seeks to reduce development time and cost by improving data availability and informing experimental workflows.